MORPHINE SULFATE ER 20 MG CAP
For 30 capsules
Pharmacies pay
$92.43 filed
30 × $3.08084 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-06-17 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$15.17 filed
30 × $0.50554 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
0.16× estimated
These two figures may not measure the same thing
At 0.16×, the Medicare figure is 0.2 times what pharmacies pay or less. A gap that large means the two figures may not describe the same unit or product, or the price may have changed between their dates; check what each one covers before relying on the multiple.
Part D averages every strength and form sold under “Morphine Sulfate ER” / “Morphine Sulfate” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-06-17 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$111.29 estimated
$92.43 + $13.86 (15%) + $5.00 fee per fill = $111.29
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-06-17 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
MORPHINE SULFATE ER 20 MG CAP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as morphine sulfate.
FDA gives its dosage form as capsule, extended release and its route as oral.
The labeler, the company named on the label, is Upsher-Smith Laboratories, LLC.
FDA’s Established Pharmacologic Class for it is Opioid Agonist.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00832-0226-00.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $92.43 for 30 capsules (30 × $3.08084 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-06-17. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 4, carried forward from the previous file.
This NDC’s NADAC was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: it took effect on 2026-06-17. The file is new; the price is not.
What NADAC measures · Why 30 capsules · NADAC explanation codes · Carried-forward prices
The NDC
- 00832-0226-00 · Upsher-Smith Laboratories, LLC · $3.08084 per EA · eff. 2026-06-17 filed carried forward
Other strengths, forms and brands
15 other products in the NADAC file share the FDA nonproprietary name morphine sulfate with MORPHINE SULFATE ER 20 MG CAP.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| MORPHINE SULF 10 MG/5 ML SOLN | $0.0431 to $0.09151 per ML filed | We don’t know yet |
| MORPHINE SULF 20 MG/5 ML SOLN | $0.11959 per ML filed | We don’t know yet |
| MORPHINE SULF 100 MG/5 ML CONC | $0.30191 to $0.45992 per ML filed | We don’t know yet |
| MORPHINE SULF ER 15 MG TABLET | $0.30984 per EA filed | $0.50554 per EA filed |
| MORPHINE SULF ER 30 MG TABLET | $0.44128 per EA filed | $0.50554 per EA filed |
| MORPHINE SULF ER 60 MG TABLET | $0.65658 per EA filed | $0.50554 per EA filed |
| MORPHINE SULF ER 100 MG TABLET | $0.85389 per EA filed | $0.50554 per EA filed |
| MORPHINE SULF ER 200 MG TABLET | $2.12665 per EA filed | $0.50554 per EA filed |
| MORPHINE SULFATE 4 MG/ML VIAL | $2.31744 per ML filed | $2.9036 per ML derived |
| MORPHINE SULFATE 10 MG/ML VIAL | $2.34224 per ML filed | $7.259 per ML derived |
| MORPHINE SULFATE ER 10 MG CAP | $2.60553 per EA filed | $0.50554 per EA filed |
| MORPHINE SULFATE ER 20 MG CAP this page | $3.08084 per EA filed | $0.50554 per EA filed |
| MORPHINE SULFATE IR 15 MG TAB | $0.22552 per EA filed | We don’t know yet |
| MORPHINE SULFATE IR 30 MG TAB | $0.3414 per EA filed | We don’t know yet |
| MS CONTIN ER 15 MG TABLET | $4.65312 per EA filed | We don’t know yet |
| MS CONTIN ER 30 MG TABLET | $8.94776 per EA filed | We don’t know yet |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. between 2026-06-17 and 2026-09-23 (4 dates) · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
Compared with its class
Its NADAC price is $3.08084 per EA filed.
Of the 108 other products in FDA’s Opioid Agonist class priced per EA, 42 have a higher middle NADAC price and 66 a lower one. The one in the middle is BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP, at $0.79784 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-06-17, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $15.17 for 30 capsules, at an average of $0.50554 per EA in 2024 (2024-01-01 to 2024-12-31) for “Morphine Sulfate ER” and “Morphine Sulfate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 1,918,463 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 capsules? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for MORPHINE SULFATE ER 20 MG CAP labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Morphine Sulfate ER / Morphine Sulfate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- HYDROCODONE-ACETAMINOPHEN 10-300 MG TABLET
- TRAMADOL HCL 100 MG TABLET
- OXYCODONE-ACETAMINOPHEN 10-325 MG TAB
- LOPERAMIDE 2 MG CAPSULE
- FENTANYL 100 MCG/HR PATCH